Crown Holdings Inc. (CCK) Intraday Market Analysis: February 20, 2025#
This report provides a comprehensive, data-driven analysis of Crown Holdings, Inc. (CCK) as of February 20, 2025. The analysis incorporates the latest financial results, market trends, and company-specific news to provide investors and analysts with actionable insights. All data is sourced from Monexa AI unless otherwise noted.
Crown Holdings Inc. (CCK) Stock Performance and Market Data#
As of February 20, 2025, Crown Holdings, Inc. (CCK) is trading at $88.67, reflecting a slight increase of +0.35% with a change of $0.31, according to Monexa AI. The stock's intraday activity shows a low of $87.71 and a high of $88.85. The trading volume stands at 1,295,113 shares, compared to its average volume of 1,356,932, indicating slightly below-average trading activity. The company's market capitalization is $10.61 billion, and it is listed on the New York Stock Exchange (NYSE). The stock's 50-day and 200-day price averages are $85.69 and $86.78, respectively, suggesting that the current price is trading above both short-term and long-term averages. The company's earnings per share (EPS) is $3.55, with a price-to-earnings (PE) ratio of 24.98, according to Monexa AI.
Key Stock Metrics#
| Metric | Value |
|---|---|
| Current Price | $88.67 |
| Change | +0.31 |
| Percentage Change | +0.35% |
| Day Low | $87.71 |
| Day High | $88.85 |
| 50-Day Average | $85.69 |
| 200-Day Average | $86.78 |
| Market Cap | $10.61 Billion |
| EPS | $3.55 |
| PE Ratio | 24.98 |
Recent News and Developments#
ProPhase Labs Announces Progress with Crown Medical Collections#
On February 20, 2025, ProPhase Labs announced significant progress with its Crown Medical Collections, targeting over $50 million in net near-term cash recovery from COVID-19 receivables, according to Monexa AI. This announcement, while directly related to ProPhase Labs (PRPH), includes the term "Crown," which may cause it to be associated with Crown Holdings, Inc. in news aggregators. The press release indicates ProPhase Labs is actively pursuing strategic alternatives, including the potential sale of Nebula Genomics and DNA Complete, to unlock immediate cash. This development highlights the importance of distinguishing between companies with similar names to avoid misattribution of news.
Crown LNG Signs Gas Sales MOU with India Gas Exchange#
On February 18, 2025, Crown LNG Holdings Limited (CGBS) announced the execution of a Memorandum of Understanding (MOU) with the India Gas Exchange Ltd. (IGX), India's first automated national-level trading platform, according to Monexa AI. This MOU aims to facilitate gas sales in India, leveraging Crown LNG's expertise in LNG liquefaction and regasification terminal technologies for harsh weather locations. This news is directly related to Crown LNG Holdings Limited (CGBS) and not Crown Holdings, Inc., but both share the term "Crown", which may cause it to be associated with Crown Holdings, Inc. in news aggregators. This underscores the need to differentiate between companies with similar names when analyzing news and market data.
Blue Crown Group Inc. and BBLC Secure Mining Lease Agreement#
On February 13, 2025, Blue Crown Group Inc. (BCGI), in collaboration with Belle Bonica Luxe Corp. (BBLC), announced the execution of a mining lease agreement for a high-potential gold project in California’s Motherlode region, according to Monexa AI. This agreement marks the first of many strategic agreements aimed at reviving overlooked, high-grade gold assets in one of the most historically productive mining districts in North America. This news is directly related to Blue Crown Group Inc. (BCGI) and not Crown Holdings, Inc., but both share the term "Crown", which may cause it to be associated with Crown Holdings, Inc. in news aggregators. This underscores the need to differentiate between companies with similar names when analyzing news and market data.
Crown Crafts Announces Third Quarter Fiscal 2025 Financial Results#
On February 12, 2025, Crown Crafts, Inc. (CRWS) reported results for the third quarter of fiscal year 2025, which ended December 29, 2024, according to Monexa AI. This announcement is specific to Crown Crafts, Inc. (CRWS) and not Crown Holdings, Inc., but both share the term "Crown", which may cause it to be associated with Crown Holdings, Inc. in news aggregators. This highlights the importance of distinguishing between companies with similar names to avoid misattribution of news.
Crown Completes Slant Wells Construction at Twin Dolphin Club in Mexico#
On February 11, 2025, Crown Electrokinetics Corp. (CRKN) announced the successful completion of its second slant well at the Twin Dolphin Club in Cabo San Lucas, Mexico, according to Monexa AI. This finalizes construction of its first slant well project. This announcement is specific to Crown Electrokinetics Corp. (CRKN) and not Crown Holdings, Inc., but both share the term "Crown", which may cause it to be associated with Crown Holdings, Inc. in news aggregators. This highlights the importance of distinguishing between companies with similar names to avoid misattribution of news.
Crown Laboratories Completes Acquisition of Revance Therapeutics#
On February 7, 2025, Crown Laboratories, Inc. completed its acquisition of Revance Therapeutics, Inc. (RVNC), according to Monexa AI. This announcement is specific to Crown Laboratories, Inc. and not Crown Holdings, Inc., but both share the term "Crown", which may cause it to be associated with Crown Holdings, Inc. in news aggregators. This highlights the importance of distinguishing between companies with similar names to avoid misattribution of news.
Crown Holdings Earnings Surpass Estimates in Q4, Sales Rise Y/Y#
On February 6, 2025, Crown Holdings, Inc. reported its Q4 2024 earnings, surpassing estimates with sales rising year-over-year, according to Monexa AI. This was driven by increased global beverage can volumes and higher North America food can shipments. This positive earnings report has likely contributed to the stock's recent performance.
Analyst Estimates#
Analyst estimates provide insights into the future financial performance of Crown Holdings, Inc.. The following table summarizes the annual analyst estimates for revenue, EBITDA, EBIT, net income, and EPS for the years 2024 through 2027, according to Monexa AI.
Annual Analyst Estimates#
| Metric | 2024 (Estimate) | 2025 (Estimate) | 2026 (Estimate) | 2027 (Estimate) |
|---|---|---|---|---|
| Revenue (Avg) | $11.78B | $11.95B | $12.23B | $12.49B |
| EBITDA (Avg) | $1.31B | $1.33B | $1.36B | $1.39B |
| EBIT (Avg) | $848.77M | $861.23M | $881.41M | $900.39M |
| Net Income (Avg) | $757.21M | $820.43M | $899.23M | $954.92M |
| EPS (Avg) | $6.33 | $6.83 | $7.47 | $8.12 |
These estimates suggest a steady growth trajectory for Crown Holdings, Inc. over the next few years, with increasing revenue, profitability, and earnings per share. However, these are estimates and actual results may vary.
Financial Ratios#
Financial ratios provide valuable insights into Crown Holdings, Inc.'s financial health and performance. The following table summarizes key financial ratios, according to Monexa AI.
Key Financial Ratios#
| Ratio | Value |
|---|---|
| Dividend Yield TTM | 0.0113 |
| PE Ratio TTM | 24.74 |
| PEG Ratio TTM | 0.073 |
| Payout Ratio TTM | 0.281 |
| Current Ratio TTM | 1.206 |
| Quick Ratio TTM | 0.837 |
| Cash Ratio TTM | 0.410 |
| Debt Ratio TTM | 0.512 |
| Debt Equity Ratio TTM | 3.051 |
| Return on Assets TTM | 0.028 |
| Return on Equity TTM | 0.171 |
| Return on Capital Employed TTM | 0.136 |
| Price to Book Ratio TTM | 4.143 |
| Price to Sales Ratio TTM | 0.898 |
These ratios indicate that Crown Holdings, Inc. has a moderate dividend yield, a reasonable PE ratio, and a relatively high debt-to-equity ratio. The company's return on equity and return on capital employed suggest that it is generating profits from its investments.
Conclusion#
Crown Holdings, Inc. (CCK) is currently trading at $88.67, showing a slight intraday increase of +0.35%, according to Monexa AI. Recent news includes progress from ProPhase Labs on Crown Medical Collections and Crown LNG's gas sales MOU with India Gas Exchange, however, these are not directly related to Crown Holdings, Inc.. The company's Q4 2024 earnings surpassed estimates, driven by increased global beverage can volumes and higher North America food can shipments. Analyst estimates suggest a steady growth trajectory for the company over the next few years. Investors should continue to monitor news, analyst estimates, and financial ratios to make informed decisions about Crown Holdings, Inc.'s stock.